¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"echo time"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hepatorenal echo contrast
    °£ÄáÆÏ¸Þ¾Æ¸®´ëÁ¶, °£½ÅÀå¿¡ÄÚ´ëÁ¶
  • homogeneous echo pattern
    ±ÕÁú¸Þ¾Æ¸®¾ç»ó
  • low echo area
    ³·Àº¸Þ¾Æ¸®¿µ¿ª, Àú¿¡ÄÚ¿µ¿ª
  • navigator echo technique
    Ç×ÇØ¿¡ÄÚ±â¹ý
  • odd echo dephasing
    Ȧ¼ö¿¡ÄÚÅ»À§»ó
  • pulse echo principle
    ÆÞ½º¿¡ÄÚ¿ø¸®
  • pulsed gradient spin echo
    ÆÞ½º±â¿ï±â½ºÇÉ¿¡ÄÚ
  • pulse-echo technique
    ÆÞ½º¿¡ÄÚ±â¹ý
  • reverberation echo
    ¹ÝÇâ¸Þ¾Æ¸®, ¹ÝÇâ¿¡ÄÚ
  • spin echo
    ½ºÇÉ¿¡ÄÚ
  • spin echo imaging
    ½ºÇÉ¿¡ÄÚ¿µ»ó
  • spin echo pulse sequence
    ½ºÇÉ¿¡ÄÚÆÞ½º¿¬¼â
  • spin echo technique
    ½ºÇÉ¿¡ÄÚ±â¹ý
  • stimulated echo acquisition mode
    Àڱظ޾Ƹ®È¹µæ¹æ½Ä, Àڱؿ¡ÄÚȹµæ¸ðµå
  • semiliquid echo pattern
    ¹Ý¾×ü¿¡ÄÚ¾ç»ó
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • inspiratory pause time
    µé¼ûÈĽ¬´Â½Ã°£, Èí±âÈÄÈÞÁö½Ã°£
  • inspiratory phase time
    µé¼û½Ã°£, Èí±â½Ã°£
  • latent time
    Àẹ½Ã°£
  • maximum phonation time
    ÃÖÀå¹ß¼ºÁö¼Ó½Ã°£
  • mean survival time
    Æò±Õ»ýÁ¸½Ã°£
  • partial thromboplastin time
    ºÎºÐÆ®·Òº¸ÇÃ¶ó½ºÆ¾½Ã°£
  • prothrombin time
    ÇÁ·ÎÆ®·Òºó½Ã°£
  • reaction time
    ¹ÝÀÀ½Ã°£
  • recovery time
    ȸº¹½Ã°£
  • repetition time
    ¹Ýº¹½Ã°£
  • scrub time
    ¼Õ¾Ä´Â½Ã°£
  • survival time
    »ýÁ¸±â°£
  • thrombin time
    Æ®·Òºó½Ã°£
  • transit time
    ÀüÀ̽ð£, Åë°ú½Ã°£
  • voiding time
    ¹è´¢½Ã°£
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • fast spin echo
    °í¼Ó½ºÇÉ¿¡ÄÚ
  • gradient echo
    ±â¿ï±â¿¡ÄÚ
  • gradient echo effect
    ±â¿ï±â¿¡ÄÚÈ¿°ú
  • pulsed gradient spin echo
    ÆÞ½º±â¿ï±â½ºÇÉ¿¡ÄÚ
  • reverberation echo
    ¹ÝÇâ¸Þ¾Æ¸®
  • spin echo
    ½ºÇɸ޾Ƹ®, ½ºÇÉ¿¡ÄÚ
  • spin echo examination
    ½ºÇÉ¿¡ÄÚ°Ë»ç
  • stimulated echo
    Àڱظ޾Ƹ®
  • fast gradient recalled echo method
    °í¼Ó±â¿ï±âȸº¹¿¡ÄÚ¹ý
  • flow sensitive gradient echo sequence
    È帧¹Î°¨±â¿ï±â¸Þ¾Æ¸®¿¬¼â
  • gradient echo imaging
    ±â¿ï±â¿¡ÄÚ¿µ»ó
  • gradient echo technique
    ±â¿ï±â¿¡ÄÚ¹ý
  • gradient echo pulse sequence
    ±â¿ï±â¸Þ¾Æ¸®ÆÞ½º¿¬¼â
  • homogeneous echo pattern
    ±ÕÁú¸Þ¾Æ¸®¾ç»ó
  • spin echo imaging
    ½ºÇÉ¿¡ÄÚ¿µ»ó
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • posterior echo
    ÈÄ¹æ ¿¡ÄÚ
  • posterior echo
    ÈĹæ (ý­Û°) ¿¡ÄÚ
  • posterior echo enhancement
    ÈÄ¹æ ¿¡ÄÚ Áõ°­, ÈÄ¹æ ¸Þ¾Æ¸®Áõ°­
  • posterior echo enhancement
    ÈĹæ (ý­Û°) ¿¡ÄÚ Áõ°­ (ñòË­), ÈĹæ (ý­Û°) ¸Þ¾Æ¸® ?
  • posterior wall echo
    Èĺ® ¿¡ÄÚ
  • posterior wall echo
    Èĺ® (ý­Ûú) ¿¡ÄÚ
  • pulse echo principle
    ÆÞ½º ¿¡ÄÚ ¿ø¸®
  • pulse echo principle
    ÆÞ½º-¿¡ÄÚ ¿ø¸® (ê«×â)
  • pulse echo techinique
    ÆÞ½º-¿¡ÄÚ ±â¹ý (ÐüÛö)
  • pulse echo technique
    ÆÞ½º ¿¡ÄÚ ±â¹ý
  • pulse-echo technique
    ÆÞ½º-¿¡ÄÚ ±â¹ý (ÐüÛö)
  • pulsed gradient spin echo (PGSE)
    ÆÞ½º °æ»ç ½ºÇÉ ¿¡ÄÚ
  • AUC : area under the concentration-time curve
    Ç÷Áß(¾à¹°)³óµµ°î¼±ÇϸéÀû.
  • BUT->breakup time of tear film
    ´«¹°¸·ÆÄ±«½Ã°£, ´©¾×¸·ÆÄ±«½Ã°£
  • Conduction time
    Àüµµ½Ã°£
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • double echo T2 weighted
    ½Ö ¿¡ÄÚ T2 °­Á¶
  • echo
    ¿¡ÄÚ, ¸Þ¾Æ¸®
  • echo amplitude
    ¿¡ÄÚ Å©±â
  • echo diplacusis
    ¹ÝÇâ(¼º) º¹Ã»
  • echo free
    ¿¡ÄÚ°¡ ¾ø´Â, ¹«¿¡ÄÚÀÇ
  • echo intensity
    ¿¡ÄÚ °­µµ
  • echo planar imaging (EPI)
    ¿¡ÄÚ Æò¸é ¿µ»ó
  • echo poor
    ¿¡ÄÚ°¡ ÀûÀº
  • echo pulse
    ¿¡ÄÚ ÆÞ½º
  • echo rich
    ¿¡ÄÚ°¡ dzºÎÇÑ
  • echo sign
    ¹ÝÇâ¡ÈÄ(¡¡¡¡¡¡).
  • echo sign of hydatid cyst
    Æ÷Ãæ³¶ÀÇ ¹ÝÇâ¡ÈÄ(øàõùÒ¥¡­ÚãúÂó£ý¦).
  • echo signal
    ¿¡ÄÚ ½ÅÈ£
  • echo spacing (ESP)
    ¿¡ÄÚ °£°Ý Àâ±â
  • echo train
    ¿¡ÄÚ ¿­
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • resolving time
    "ºÐ¸®½Ã°£, ÇØ»ó½Ã°£"
  • retention time
    ¸Ó¹«¸§ ½Ã°£
  • rotational relaxation time
    ȸÀü À̿Ͻð£(üÞï®ì¬èÐãÁÊà)
  • thermal death time
    ¿­»ç½Ã°£ (æðÞÝãÁÊà)
  • time constant
    ½Ã°£»ó¼ö (ãÁÊàßÈâ¦)
  • time constant of a reaction
    ¹ÝÀÀ ½Ã°£»ó¼ö (ÚãëëãÁÊàßÈâ¦)
  • time factor effect
    ½Ã°£ÀÎÀÚ È¿°ú (ãÁÊàì×í­üùÍý)
  • transient time
    °úµµ±â ½Ã°£(ΦԤѢãÁÊà)
  • turnover time
    Àüȯ½Ã°£(ï®üµãÁÊà)
  • zero time binding DNA
    ¿µ½Ã(çÍãÁ) °áÇÕ(Ì¿ùê) DNA
  • zero time control
    ¿µ½Ã(çÍãÁ) ´ëÁ¶(ÓßðÎ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • longitudinal relaxation time
    Á¾ÃàÀ̿Ͻð£
  • mean survival time
    Æò±Õ»ýÁ¸½Ã°£
  • polymerizing time
    ±»´Â½Ã°£, ÁßÇսð£
  • prothrombin time
    ÇÁ·ÎÆ®·Òºó½Ã°£
  • pulmonary circulation time
    Æó¼øÈ¯½Ã°£
  • real time
    ½Ç½Ã°£, Áï½Ã
  • real time acquisition
    ½Ç½Ã°£È¹µæ
  • real time display
    ½Ç½Ã°£Ç¥½Ã
  • real time image
    ½Ç½Ã°£¿µ»ó
  • real time imaging
    ½Ç½Ã°£¿µ»ó±â¹ý
  • real time study
    ½Ç½Ã°£°Ë»ç
  • real time system
    ½Ç½Ã°£Ã¼°è
  • recovery time
    ȸº¹±â°£, ȸº¹ ½Ã°£
  • relaxation time
    À̿Ͻð£
  • repetition time [=TR]
    ¹Ýº¹½Ã°£
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ST esotropia; scala tympani; scaphotrapezoid; sclerotherapy; sedimentation time; semitendinosus; sensor...
TT tablet triturate; tactile tension; tendon transfer; test tube; testicular torsion; tetanus toxin; te...
TE Time to Echo
CRT cadaveric renal transplant; cardiac resuscitation team; cathode-ray tube; certified; Certified Recor...
ET educational therapy; effective temperature; ejection time; embryo transfer; endothelin; endotoxin; e...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
EP Echo Planar
EPI Echo Planar Imaging
ETL echo train length
ECHO Echocardiograms
ECHO Echocardiographic
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • even echo rephasing
    ¦¼ö ¿¡ÄÚ ÀçÀ§»ó
  • fast gradient recalled echo method
    °í¼Ó °æ»ç ȸº¹ ¿¡ÄÚ ±â¹ý
  • fast spin echo
    °í¼Ó ½ºÇÉ ¿¡ÄÚ
  • field echo
    ÀÚÀå ¿¡ÄÚ
  • fractional echo imaging
    ºÐÇÒ ¿¡ÄÚ ¿µ»ó
  • hepato renal echo contrast
    °£ ½ÅÀå ¿¡ÄÚ ´ëÁ¶
  • internal echo
    ³»ºÎ ¿¡ÄÚ
  • lateral wall echo
    Ãøº® ¸Þ¾Æ¸®
  • marginal echo
    °¡ÀåÀÚ¸® ¿¡ÄÚ, ÁÖº¯ ¿¡ÄÚ
  • midline echo shift
    Á¤Áß¼± ¿¡ÄÚ º¯À§
  • mixed echo
    È¥ÇÕ ¿¡ÄÚ, È¥ÇÕ ¸Þ¾Æ¸®
  • partial echo imaging
    ºÎºÐ ¿¡ÄÚ ¿µ»ó
  • posterior echo
    ÈÄ¹æ ¿¡ÄÚ
  • pulse echo principle
    ÆÞ½º ¿¡ÄÚ ¿ø¸®
  • rephasing even echo
    ÀçÀ§»ó ¦¼ö ¿¡ÄÚ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
bleeding time <haematology> A test which measures the time it takes for small blood vessels to close off and bleeding to stop. Abnormal results can be seen in those with congenital or acquired platelet function disorders or thrombocytopenia.
(27 Sep 1997)
blood circulation time Determination of the shortest time interval between the injection of a substance in the vein and its arrival at some distant site in sufficient concentration to produce a recognizable end result. It represents approximately the inverse of the average velocity of blood flow between two points.
(12 Dec 1998)
P-A conduction time See: atrioventricular conduction.
(05 Mar 2000)
generation time <cell biology> Time taken for a cell population to double in numbers and thus equivalent to the average length of the cell cycle.
(18 Nov 1997)
reaction time The time from the onset of a stimulus until the organism responds.
(12 Dec 1998)
real-time ultrasonography Rapid serial ultrasound images produced using a phased array or scanning transducer; produces a video display of organ motion, such as heart valve or foetal motion.
(05 Mar 2000)
recognition time The interval between the application of a stimulus and the recognition of its nature.
(05 Mar 2000)
partial thromboplastin time Test of the intrinsic (factors viii, ix, xi, and xii) and common (fibrinogen, prothrombin, factors v and x) pathways of coagulation in which a mixture of plasma and phospholipid platelet substitute (e.g., crude cephalins, soybean phosphatides) is recalcified and the time required for the appearance of fibrin strands measured. Activation may be provided by contact with the glass tube or exposure to activators (e.g., ellagic acid, particulate silicates such as diatomaceous earth or kaolin) before addition of the calcium chloride. It is used as a screening test and to monitor heparin therapy.
(12 Dec 1998)
relaxation time Time taken for a system to return to the resting or ground state or a new equilibrium state following perturbation. Often used in context of receptor systems that have a refractory period after responding and then relax to a competent state. Can be used more precisely to mean the time for a system to change from its original equilibrium value to 1/e of this original value.
(18 Nov 1997)
median time to elimination <pharmacology> The time it takes one half of a drug to be eliminated from the body.
(09 Oct 1997)
repetition time In magnetic resonance imaging, the time between repetitions of the pulse sequence.
(05 Mar 2000)
rise time The time required for a pulse or echo to rise from 10% to 90% of its peak amplitude.
(05 Mar 2000)
P-H conduction time See: atrioventricular conduction.
(05 Mar 2000)
running time The time during which an activity (e.g., chromatography development) occurs.
(05 Mar 2000)
Russell's viper venom clotting time A clotting time determination performed on citrated platelet-poor plasma using Russell's viper venom as an activating agent. This allows activation of factor X directly without the need for other coagulation factors and is used to confirm factor X defects.
See: Stypven time test.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • behind time
    ´ÊÀº
  • bide one's time
    ÁÁÀº½Ã±â¸¦ ±â´Ù¸®´Ù
  • by that time
    ±×¶§±îÁö
  • by the time
    ±×¶§Âë¿¡
  • by-time
    ¿©°¡
  • for the first time
    óÀ½À¸·Î
  • high time
    ²À ¾Ë¸ÂÀº ¶§
  • in time
    ½Ã°£¿¡ ¸Â°Ô
  • lose no time in
    °ð - ÇÏ´Ù
  • mark time
    Á¦ÀÚ¸® °ÉÀ½ÇÏ´Ù
  • on time
    Á¤°¢¿¡
  • once upon a time
    ¿¾³¯¿¡
  • some other time
    ¾ðÁ¨°¡ µý³¯¿¡(=some other day)
  • some time
    ¾ðÁ¨°¡,Àá½Ã
  • time
    ½Ã°£,°èÀý,(º¹¼ö)½Ã´ë,-ȸ(¹è)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á